Leptin has been shown to reduce body fat in vivo. Adipocytes express the leptin receptor, therefore it is realistic to expect a direct effect of leptin on adipocyte growth and metabolism. In vitro studies examining the effect of leptin on adipocyte metabolism require supraphysiologic doses of the protein to see a decrease in lipogenesis or stimulation of lipolysis, implying an indirect action of leptin. It is also possible that leptin reduces adipose mass by inhibiting preadipocyte proliferation (increase in cell number) and/or differentiation (lipid filling). Thus, we determined direct and indirect effects of leptin on preadipocyte proliferation and differentiation in vitro. We tested the effect of leptin (0-500 ng/ml), serum from leptin infused rats (0.25% by volume), and adipose tissue conditioned media from leptin infused rats (0-30% by volume) on preadipocyte proliferation and differentiation in a primary culture of cells from male Sprague-Dawley rat adipose tissue. Leptin (50 ng/ml) stimulated proliferation of preadipocytes (P< 0.05), but 250 and 500 ng leptin/ml inhibited proliferation of both preadipocyte and stromal vascular cell fractions (P< 0.01), as measured by 3 H-thymidine incorporation. Serum from leptin infused rats inhibited proliferation of the adipose and stromal vascular (P = 0.01) fractions, but adipose tissue conditioned media had no effect on proliferation of either cell fraction. None of the treatments changed preadipocyte differentiation as measured by GPDH activity. These results suggest that leptin could inhibit preadipocyte proliferation by modifying release of a factor from tissue other than adipose tissue.
INTRODUCTION
Parabiosis studies in genetically obese mice indicate that there is a circulating factor involved in the regulation of food intake and body weight (12, 24) . Leptin, a circulating hormone produced by the obese (ob) gene in adipose tissue (63) , has been shown experimentally to reduce body weight by decreasing food intake and increasing energy expenditure in rodents (45, 22) . The reduction in body weight is specific to fat, as there is no loss of lean mass in leptin-treated animals (45) .
Leptin initiates biological responses by binding to its receptor, Ob-R, which is found in the brain and most peripheral tissues, including white adipose tissue (55) . Direct injections of leptin into the brain of rodents decrease appetite and body fat (11) , so it was initially thought that leptin exerted its effects exclusively by binding receptors in the central nervous system (55) .
Peripheral infusions of leptin in mice also reduce body weight and body fat content (27) and this can be achieved without producing a significant reduction in food intake (9) . Some of the responses to peripherally administered leptin may be mediated by leptin crossing the blood brain barrier and activating leptin receptors in brain that are associated with the control of food intake or energy metabolism, but others may be dependent upon activation of leptin receptors in peripheral tissue (see (7) for review).
The specific pathways that are responsible for the loss of fat in leptin-treated animals have not been fully elucidated and more attention has been paid to changes in lipid metabolism of mature fat cells than responses made by preadipocytes that are destined to become fat cells.
Studies examining metabolism in mature, lipid-filled fat cells have shown that leptin stimulates adipose tissue lipolysis both in vitro (21, 60) and in vivo (20) , stimulates fatty acid oxidation (64) and inhibits insulin-stimulated lipogenesis both in vivo (23) and in vitro (5) but does not inhibit basal lipogenesis in vivo (23) . The in vitro studies indicate that leptin has the potential to directly activate adipose tissue leptin receptors, however, very high concentrations of leptin are required to stimulate lipolysis in vitro (21) compared with those that are effective in vivo (20) which suggests the involvement of additional factors in vivo that either enhance or mediate the leptin response. In vivo, leptin may stimulate lipolysis in adipocytes directly or indirectly either by inducing release of another circulating factor or by activating the sympathetic nervous system. Several studies have shown that leptin can activate sympathetic outflow to tissues such as brown adipose tissue (51) and the kidneys (30) but it is not yet clear whether there is a biologically significant stimulation of sympathetic activity in white adipose tissue (13) .
In addition to increasing lipolysis and fatty acid oxidation and decreasing insulinstimulated lipogenesis to reduce the size of mature, lipid-filled fat cells leptin may affect the size of white adipose depots by inhibiting proliferation and/or differentiation of preadipocytes. Only two studies have examined the effect of leptin on preadipocyte proliferation (36, 47). One study showed that 160 ng/ml murine leptin increased proliferation in a primary culture of rat stromal vascular cells, but stromal vascular cells were not separated from adipocytes, so it is uncertain whether proliferation could be attributed to preadipocytes, stromal vascular cells or both (36).
Ramsay (47) found increased proliferation in porcine preadipocytes treated with 1,000 ng/ml porcine leptin. The large difference in the dose required to increase proliferation in the two studies could be due to the different sources of cells and leptin or due to the cell type responsible for the proliferation. Three studies have examined the effect of leptin on preadipocyte differentiation in vitro (36, 47, 56) . One study reported an inhibition of differentiation of preadipocytes derived from a human marrow stromal cell line (56), the second study reported an increase in differentiation of preadipocytes derived from white fat obtained from male Sprague-Dawley rats (36) and the third study found no effect of leptin on differentiation of porcine preadipocytes (47) .
The purpose of the studies described here was to determine whether leptin affected proliferation and/or differentiation of preadipocytes derived from rat adipose tissue and, if there was an effect, whether it is due to a direct action of leptin on the cells or whether it was mediated by another circulating factor originating in adipose tissue.
MATERIALS AND METHODS
All animal procedures were approved by the Institutional Animal Care and Use Committee of the University of Georgia and were conducted according to American Physiology Society Guiding Principles in the Care and Use of Animals (3).
Cell Culture Techniques
Inguinal fat pads were removed aseptically from male Sprague-Dawley rats (Harlan Industries, Indianapolis, IN), weighing 80-100 g, following the technique described in detail previously (48) . Briefly, rats were anesthetized with ketamine (200mg/kg body weight i.p.) and xylazine (10mg/kg i.p.) before removal of inguinal fat pads in sterile conditions. Fat was minced with scissors and incubated with shaking in digestion buffer (HEPES containing 1000 units/ml collagenase) for 90-120 minutes at 37˚ C. The fat was filtered through 240 and 20 µm mesh filters, and undigested fat was discarded. 
Conditioned Media and Serum from Leptin Treated Rats
Twenty two male Sprague-Dawley rats (Harlan Industries) weighing between 320 and 340 grams were housed in hanging wire mesh cages at 23° C, with lights on 12 hours/day from 7:00 a.m., and free access to chow (Purina Rodent chow 5001: Purina Mills, St. Louis, MO). After a 7 day acclimation period, daily food intakes and body weights were recorded. After 3 days of baseline measures, rats were weight matched into two groups and fitted with intraperitoneal Alzet miniosmotic pumps (Direct Corp. Cupertino, CA Model 1007D) which delivered either 100 µg recombinant rat leptin (R&D Systems, Minneapolis, MN) in PBS or an equivalent volume of PBS over 24 hours for five days. Blood was collected on the third day of infusion by tailbleed for measurement of serum leptin (Rat Leptin RIA kit: Linco, St. Louis, MO). After 5 days of infusion, rats were killed, trunk blood collected, and epididymal, retroperitoneal, perirenal, and mesenteric fat pads dissected and weighed. Serum leptin concentrations were measured and serum was added to the cell culture assays where indicated below.
Epididymal and retroperitoneal fat pads from the leptin-and PBS-infused rats were washed with saline and weighed. A small portion (50-100 mg) of fat was fixed in osmium tetroxide solution for determination of cell number by Coulter Counter and Multisizer as described previously (38) . Cell number was subsequently used to adjust the volume of the conditioned media to normalize volume based on the number of cells that were present in the incubated fat.
Large blood vessels were removed from the remaining fat, which was minced and washed 3-4 times with Hank's Balanced Salt Solution (HBSS) and filtered through Fisherbrand P8 filter paper (Fisher Scientific, Pittsburgh, PA) to remove excess solution. Fat was reweighed and incubated with 10 volumes of DMEM/F12 in 12.5 cm 3 incubation flasks for 4 hours at 37° C and 5%
humidity. DMEM/F12 containing no adipose tissue also was incubated and used as a control in the cell culture assays, as described below. Following the incubation period, conditioned media and DMEM/F12 were filtered through Fisherbrand P8 filter paper. The filtered media was then sterile filtered (Steriflip Filters, 0.22 µm,), frozen at -80° C and later diluted with varying amounts of DMEM/F12 to equalize volume based on cell number counts.
Experiment 1
Proliferation and differentiation assays were performed on 6 different pools (1 pool = 2 rats) of cells and treatments were run in quadruplicate on each pool of cells. Treatment media for both the proliferation and differentiation assays consisted of varying concentrations of leptin (5, 50, 100, 250, 500 ng/ml) added to the basal control medium described above. AraC (536 nM), a DNA synthesis inhibitor, was used as a negative control for preadipocyte proliferation and 10 nM IGF-1 was used as a positive control. TNF-α (1 nM) was used as a negative control for preadipocyte differentiation and 1000 nM insulin was used as a positive control.
Lactate Dehydrogenase Assay
On Days 4 and 5 of the proliferation assay (days 2 and 3 of exposure to treatments), media from cells treated with 100 ng/ml leptin or 536 nM AraC was collected and assayed for lactate dehdyrogenase (LDH) using a kit (Sigma DG1340-K: Sigma Chemical Co.) according to the manufacturers protocol. This provided a measure of cell damage.
Experiment 2
Basal test medium for both the proliferation and differentiation assays was supplemented with 0.25% serum by volume from each of the leptin-and PBS-infused rats. Treatment serum replaced the control rat serum in the proliferation assay. In addition, various concentrations by volume of conditioned media (5, 10, 20, or 30%) were added to basal test medium. Each conditioned media treatment was diluted to be equivalent of having been exposed to 150,000 adipocytes/ml before it was added to the basal medium. Serum and conditioned media collected from the same rat were added as treatments to the same pool of cultured cells. Positive and negative controls were the same as in Experiment 1. DMEM/F12 media that had not been exposed to adipose tissue (5, 10, 20, or 30% by volume) was used as a control. Conditioned media was analyzed for free fatty acid (NEFA C Kit, Wako Chemicals, GMbH, Germany) and triglyceride (L-Type TG-H Kit, Wako Chemicals) concentrations according to the manufacturer's protocols. The leptin concentrations of the media also was measured and found to be at, or below, the lowest detectable level of the assay (0.5 ng/ml: data not shown).
Statistical Analysis
One-way ANOVA (Statistica Software 99' Edition, Stat Soft, Tulsa, OK) was used to compare dose dependent differences in preadipocyte and stromal vascular proliferation and preadipocyte differentiation in Experiment 1. Two-way ANOVA was used to compare the effects of type and volume of media on preadipocyte and SV proliferation or preadipocyte differentiation in Experiment 2. Post hoc comparisons were made using Duncan's multiple-range
test. An unpaired t-test was used to compare the differences in body weight, fat pad weight, food intake and serum leptin levels of the infused rats and to test the effect of serum from leptin or PBS infused rats on preadipocyte and SV proliferation in Experiment 2. Differences were considered significant at P < 0.05.
RESULTS

Experiment 1
Leptin had a biphasic effect on preadipocyte proliferation. A concentration of 50 ng/ml leptin significantly increased preadipocyte proliferation (P< 0.05), while 250 and 500 ng/ml leptin significantly decreased proliferation (P< 0.01: Figure 1A) . Similarly, 250 and 500 ng/ml leptin significantly decreased SV cell proliferation (P< 0.01: Figure 1B ). As expected, IGF-1 stimulated proliferation of both the adipose and SV fractions, by 49 and 23% respectively, compared to control ( Figures 1A and 1B) . AraC decreased preadipocyte and SV cell proliferation by 45 and 83% respectively compared with control ( Figures 1A and 1B) . Leptin had no effect on preadipocyte differentiation as measured by GPDH activity (data not shown), whereas 1 nM TNF-α decreased GPDH activity by 59% and 1000 nM insulin increased it by 59% compared with control.
Media collected from cultures exposed to 100 ng/ml leptin or AraC treatments had significantly less LDH activity than the lipid calibrator provided by the manufacturer (Figure 2 ), indicating that the inhibition of proliferation in cells treated with leptin or AraC was not associated with substantial levels of cell death.
Experiment 2
There was no significant difference in beginning body weight, end body weight, food intake or epididymal, retroperitoneal or perirenal fat pad weights between rats infused with 100 ug leptin per day or with PBS for 5 days (Table 1) . Leptin infused rats gained significantly less weight during infusion, had smaller mesenteric fat pads (P< 0.05) and had significantly higher serum leptin levels on both days 3 and 5 of infusion compared with PBS infused rats (P< 0.01: Table 1 ). The control rat serum, which was used in the test media for the proliferation assay, contained significantly more leptin (8.3 ng/ml) than serum from leptin-or PBS-infused rats on day 5.
Serum from leptin treated rats inhibited proliferation of preadipocytes (P = 0.01) and SV cells (P = 0.01) compared with serum from PBS-infused rats ( Figure 3 ) but did not effect preadipocyte differentiation (data not shown). There was no difference in preadipocyte or SV cell proliferation or in preadipocyte differentiation of cells exposed to adipose tissue conditioned media from leptin-or PBS-infused rats, and there was no interaction between volume and source of media on proliferation (adipose tissue conditioned media or control conditioned media) ( Table   2 ). In contrast, all concentrations of adipose conditioned media significantly increased preadipocyte differentiation compared with conditioned media not exposed to adipose tissue (Table 3 ). There were no differences in the FFA or triglyceride concentrations of the conditioned media from PBS-and leptin-infused rats (FFA: 0.10 + 0.01 and 0.09 + 0.01ng/ml for PBS and leptin-infused conditioned media respectively. Triglycerides: 32 + 5 and 31 + 7 mEq/L for PBS and leptin-infused conditioned media respectively). IGF-1 and AraC significantly increased and decreased preadipocyte and SV proliferation, respectively (P < 0.05: data not shown).
Preadipocyte differentiation was significantly increased by 1000 nM insulin and decreased by 1 nM TNF-α (data not shown).
DISCUSSION
In this experiment, we examined whether leptin modified preadipocyte development (proliferation and/or differentiation) directly and/or indirectly. Leptin alone had a biphasic effect on preadipocyte proliferation. A relatively low concentration of 50 ng/ml leptin significantly increased preadipocyte proliferation, whereas 250 and 500 ng/ml leptin significantly inhibited both preadipocyte and stromal vascular proliferation. In contrast, very low concentrations of serum from leptin-infused rats decreased proliferation of both adipose and stromal vascular cell fractions compared with serum from PBS-infused rats. These results imply that leptin can modify the rate of growth of adipose depots indirectly, possibly by activating or inhibiting another circulating factor, to decrease proliferation. Although 0.25% by volume serum from leptin-infused rats decreased preadipocyte and SV proliferation, concentrations of up to 30% by volume of adipose tissue conditioned media had no effect on cell proliferation, indicating that the active inhibitory factor is unlikely to be released from white fat. In contrast, although neither leptin nor serum from leptin-infused rats influenced preadipocyte differentiation, adipose conditioned media from both leptin-and PBS-infused rats significantly increased preadipocyte differentiation, implying that there is at least one factor released from fat that stimulates preadipocyte differentiation. It also is possible that the increased differentiation was due to increased availability of fatty acids and triglycerides, but this is unlikely because the response was not dose dependent.
It may not be surprising that leptin increased preadipocyte proliferation since the protein increases proliferation of other cell types, such as hematopoietic and endothelial cells (37) . In addition, other investigators have reported that leptin increases preadipocyte proliferation in primary culture (36, 47). Adipocytes express the leptin receptor (53) making it possible for leptin to act directly on adipocytes and preadipocytes to regulate growth and metabolism. The amount of leptin required to stimulate proliferation in preadipocytes in vitro was higher that the circulating concentrations found in normal animals. In young rats, physiologic levels of circulating leptin are about 5 ng/ml and levels increase with age and adiposity (44) exceeding concentrations of 50 ng/ml in genetically obese animals (25) . Similar circulating concentrations of leptin have been reported for humans (14) . The concentration of leptin in extracellular fluid surrounding adipocytes may be significantly higher than that in the circulation, thus leptin could function as a paracrine regulator of preadipocyte proliferation in fat depots. Expression of leptin mRNA varies across different fat depots and correlates with fat cell size (37, 26) . In rats leptin mRNA expression is higher in retroperitoneal and parametrial fat than in perirenal or inguinal fat (46), so it cannot be ruled out that higher doses of leptin caused cell death in this study, however, necrosis was not present in cells treated with 100 ng/ml leptin.
Leptin had no direct effect on preadipocyte differentiation, consistent with the results of Ramsay (47) . Serum and adipose tissue conditioned media from leptin-infused rats did not affect preadipocyte differentiation compared to serum or conditioned media from PBS-infused rats. As expected, positive and negative controls increased and decreased preadipocyte differentiation respectively, therefore if leptin alone, serum from leptin-infused animals, or adipose tissue conditioned media from leptin-infused animals induced a change in preadipocyte differentiation, the response would have been detected. This negative result was somewhat surprising since leptin has been shown to reduce the size of mature adipocytes by inhibiting insulin-stimulated lipogenesis (23, 5) and by increasing lipolysis (20, 21) and fatty acid oxidation (64). Recent studies have clarified the post-receptor signaling events and involvement of specific transcription factors involved in the mediation of different aspects of leptin activity (6, 19, 42) , including changes in lipid and glucose metabolism of mature adipocytes (34, 39) , but little is known about the effect of leptin on preadipocyte proliferation. It is likely that early stages of the signaling processes that mediate changes in rates of preadipocyte proliferation are similar to those in other tissue types and are associated with activation of MAPK (35, 8) . In this study we used a primary culture of SV cells, therefore, differences in metabolism of preadipocytes compared with differentiated adipocytes could explain why we did not see an effect of leptin on the lipid filling of preadipocytes. The SV cells used in this study were obtained from inguinal fat which is a depot that tends to enlarge during aging by hyperplasia rather than hypertrophy (16) and it is possible that SV cells derived from other fat depots, such as epididymal or mesenteric fat, which enlarge by hypertrophy (16) , would have shown less of a proliferative response to leptin.
Consistent with this notion, in previous studies we have found that peripheral infusions of leptin cause reliable changes in the size of both inguinal and retroperitoneal fat depots in rats but have a smaller impact on the size of epididymal and mesenteric fat (49). Further experiments are needed to determine whether the effect of leptin on preadipocyte proliferation is depot specific because the two other studies that have reported an effect of leptin on preadipocyte proliferation also used cells from subcutaneous adipose tissue (36, 47).
In the second study reported here low concentrations of serum from leptin-infused rats significantly inhibited proliferation of both preadipocytes and SV cells. The results from the first experiment and the fact that the control pool of serum used for the basal media contained more leptin than the test media from leptin-treated rats confirmed that high serum leptin concentrations could not account for the inhibition of proliferation. These data imply that leptin treatment results in the release, or inhibition, of another metabolically active circulating factor which influences preadipocyte growth. These results are consistent with observations that leptin increases endothelial cell proliferation in vitro (8) , but decreases proliferation in vivo (50), implying that there are additional factors involved in the in vivo response to leptin. Although leptin has been reported to stimulate sympathetic outflow to some tissues (29) and that increased sympathetic activity inhibits adipocyte proliferation (10), this mechanism cannot account for changes in cell number in an in vitro condition. It is possible, however, that leptin stimulated the release of norepinephrine, which has been shown to inhibit preadipocyte proliferation (32). This is not likely the factor responsible for decreased proliferation in this study because norepinephrine becomes unstable once blood is collected unless preservatives are added (15).
Many studies have examined the relationship between leptin and other cytokines, hormones, and factors secreted from non-adipose tissues (58) . TNFα is produced by non-adipocyte cells in adipose tissue and is increased in tissue from obese individuals (17) . Although TNFα has been shown to inhibit preadipocyte proliferation in primary rat preadipocyte culture (33) it is released extremely slowly from adipose tissue into the circulation (40) (57) . Therefore, it is possible that leptin activates a factor such as IL-15 to inhibit preadipocyte proliferation. Another factor that may be involved is alpha melanocyte stimulating hormone (αMSH). Recent studies have shown significant weight loss in ob/ob mice treated with an αMSH analog (18) and that leptin administration doubles circulating concentrations of αMSH in these mice (31) . In vitro, αMSH decreases adipocyte leptin expression and secretion (31) . Therefore, a possible feedback loop exists between αMSH and leptin, in which leptin increases αMSH secretion and αMSH downregulates leptin expression and secretion.
The source of the serum factor responsible for decreasing proliferation is unknown.
Leptin is produced by adipose tissue in proportion to the amount of fat present (62) and reduces body fat mass in experimental animals (45) , so it is reasonable to assume that the factor might be produced by adipocytes. In Experiment 2, however, we found no difference in preadipocyte or SV proliferation in cells treated with conditioned media from leptin-or PBS-infused rats or with non-adipose control conditioned media, suggesting that leptin does not activate a factor released from fat to decrease proliferation. Alternatively, the serum factor may have been derived from adipose tissue but was present at low concentrations in conditioned media. This should have been, at least partially, accounted for by the 120-fold higher concentrations of conditioned media tested (30% by volume) compared with the effective concentrations of serum (0.25% by volume). It also is possible that the four hour exposure of media to adipose tissue did not allow enough time for the factor to be secreted from adipose tissue. In contrast to the absence of any effect on proliferation, adipose tissue conditioned media from both leptin-and PBS-infused rats significantly increased preadipocyte differentiation, implying that a factor released from fat promotes lipid filling. Fatty acids and triglycerides were present at low levels in conditioned media, therefore they could not account for the increase in lipid filling of preadipocytes. Other factors released from fat, such as IGF-1, may have been responsible for increased preadipocyte differentiation (28), but we did not measure the IGF-1 concentrations in the conditioned media.
In summary, the studies described here demonstrate that leptin can act directly on adipose tissue to increase preadipocyte proliferation and indirectly to inhibit preadipocyte and SV proliferation. The inhibition appears to be due to the activation or inhibition of an additional circulating factor and further studies are needed to identify this factor. Leptin had no direct or indirect effect on preadipocyte differentiation, despite evidence for inhibition of insulin-stimulated lipogenesis and increased lipolysis on mature adipocytes. The results of these studies reinforce the complexity of leptin action, but provide new insights into its role in preadipocyte development. Table 1 . Body weight, change in body weight, fat pad weights and leptin levels after leptin and PBS infusion for 5 days.
PBS Leptin
Start body weight (g) 340 ± 6 339 ± 5
End body weight (g) 344 ± 6 336 ± 5
Weight change (g/5 day) 3.6 ± 2.0 -2.8 ± 2. Values are means ± sem for 6-9 rats in the leptin group and 7-10 in the PBS group. An asterisk indicates a significant difference (P < 0.05) between leptin and PBS infused rats. Data are means ± sem (n= 6-7 rats), with each sample tested in triplicate. There was no difference in preadipocyte proliferation within or between leptin-and PBS-infused groups.
There was no interaction between volume of media or type of media (adipose tissue conditioned media or control conditioned media).
conditioned media and control conditioned media. Data are means ± sem (n= 6-7 rats), with each sample tested in triplicate. There was no difference in differentiation within or between leptin-and PBS-infused groups. An asterisk indicates that there was a significant difference (P < 0.05) between adipose tissue conditioned media and control media not exposed to adipose tissue. Incorporation of 3 H-thymidine into the preadipocyte and SV cell fractions treated with 0.25% serum from rats infused with PBS or leptin. Data represents mean + sem for 6-10 rats, with each treatment determined in triplicate. An asterisk indicates a significant difference between cells exposed to serum from PBS-infused and leptininfused rats (P<0.01) Figure 3 
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